Last reviewed · How we verify
Carboplatin AUC6 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Carboplatin AUC6 (Carboplatin AUC6) — Merck Sharp & Dohme LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Carboplatin AUC6 TARGET | Carboplatin AUC6 | Merck Sharp & Dohme LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Carboplatin AUC6 CI watch — RSS
- Carboplatin AUC6 CI watch — Atom
- Carboplatin AUC6 CI watch — JSON
- Carboplatin AUC6 alone — RSS
Cite this brief
Drug Landscape (2026). Carboplatin AUC6 — Competitive Intelligence Brief. https://druglandscape.com/ci/carboplatin-auc6. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab